Evoke Pharma, Inc. (EVOK) Net Income by Year
Evoke Pharma, Inc. reported a net loss of $5.4M in fiscal year 2024. This represents an increase of 31.3% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a $5.2M net loss. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Evoke Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EVOK Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$5.2M | -$5.4M+31.3% | -$7.8M-45.6% | -$5.4M+37.3% | -$8.5M+35.1% | -$13.2M-84.6% | -$7.1M+5.8% | -$7.6M+38.1% | -$12.2M-13.8% | -$10.7M+11.3% | -$12.1M+8.5% | -$13.2M-367.0% | -$2.8M | N/A | -$2.4M+52.4% | -$5.0M |
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
EVOK Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Evoke Pharma, Inc. financials
Frequently Asked Questions
What was Evoke Pharma, Inc.'s net income in fiscal year 2024?
Evoke Pharma, Inc. reported a net loss of $5.4M in fiscal year 2024.
How fast is Evoke Pharma, Inc.'s net income growing?
Evoke Pharma, Inc. (EVOK) net income rose by 31.3% year over year, from -$7.8M to -$5.4M in fiscal year 2024.
What is Evoke Pharma, Inc.'s net income over the last twelve months?
Evoke Pharma, Inc. (EVOK) reported a $5.2M net loss over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Evoke Pharma, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Evoke Pharma, Inc. (EVOK) net income went from -$5.0M in fiscal year 2010 to -$5.4M in fiscal year 2024.
What was Evoke Pharma, Inc.'s net income in the most recent quarter?
Evoke Pharma, Inc. (EVOK) reported -$1.2M in net income in Q3 2025. This represents an increase of 11.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Evoke Pharma, Inc. (EVOK) reported on that line in every period on record.